These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
124 related items for PubMed ID: 32031353
1. [Use of a xenogeneic collagen matrix on extraction sockets: a new approach in ARONJ prevention (in german)]. Kuster I, Valdec S, Rücker M, Bichsel D. Swiss Dent J; 2020 Feb 10; 130(2):139-145. PubMed ID: 32031353 [Abstract] [Full Text] [Related]
2. Incidence and risk of antiresorptive agent-related osteonecrosis of the jaw (ARONJ) after tooth extraction in patients with autoimmune disease. Fujieda Y, Doi M, Asaka T, Ota M, Hisada R, Ohnishi N, Kono M, Kameda H, Nakazawa D, Kato M, Amengual O, Takahata M, Yasuda S, Kitagawa Y, Atsumi T. J Bone Miner Metab; 2020 Jul 10; 38(4):581-588. PubMed ID: 32076874 [Abstract] [Full Text] [Related]
3. Antiresorptive Agent-Related Osteonecrosis of the Jaw (ARONJ): A Twist of Fate in the Bone. Shibahara T. Tohoku J Exp Med; 2019 Feb 10; 247(2):75-86. PubMed ID: 30713280 [Abstract] [Full Text] [Related]
4. Tooth extractions in patients under antiresorptive therapy for osteoporosis: Primary closure of the extraction socket with a mucoperiosteal flap versus application of platelet-rich fibrin for the prevention of antiresorptive agent-related osteonecrosis of the jaw. Poxleitner P, Steybe D, Kroneberg P, Ermer MA, Yalcin-Ülker GM, Schmelzeisen R, Voss PJ. J Craniomaxillofac Surg; 2020 Apr 10; 48(4):444-451. PubMed ID: 32122726 [Abstract] [Full Text] [Related]
5. Evaluation of Preventive Treatment Protocols for Patients under Antiresorptive Therapy Undergoing Tooth Extraction at a Swiss University Clinic. Pick E, Leuenberger N, Kuster I, Stutzmann NS, Stadlinger B, Valdec S. Int J Environ Res Public Health; 2021 Sep 21; 18(18):. PubMed ID: 34574862 [Abstract] [Full Text] [Related]
6. CT imaging features of antiresorptive agent-related osteonecrosis of the jaw/medication-related osteonecrosis of the jaw. Baba A, Goto TK, Ojiri H, Takagiwa M, Hiraga C, Okamura M, Hasegawa S, Okuyama Y, Ogino N, Yamauchi H, Kobashi Y, Yamazoe S, Munetomo Y, Mogami T, Nomura T. Dentomaxillofac Radiol; 2018 May 21; 47(4):20170323. PubMed ID: 29365278 [Abstract] [Full Text] [Related]
7. Osteonecrosis of the jaw in patients transitioning from bisphosphonates to denosumab treatment for osteoporosis. Voss PJ, Steybe D, Poxleitner P, Schmelzeisen R, Munzenmayer C, Fuellgraf H, Stricker A, Semper-Hogg W. Odontology; 2018 Oct 21; 106(4):469-480. PubMed ID: 29713913 [Abstract] [Full Text] [Related]
8. Local RANKL delivery improves socket healing in bisphosphonate treated rats. Soundia A, Hadaya D, Chau Y, Gkouveris I, Bezouglaia O, Dry S, Pirih F, Aghaloo T, Tetradis S. Bone; 2021 Jul 21; 148():115945. PubMed ID: 33836308 [Abstract] [Full Text] [Related]
9. Effect of bisphosphonates on healing of tooth extraction wounds in infectious osteomyelitis of the jaw. Yamashita J, Sawa N, Sawa Y, Miyazono S. Bone; 2021 Feb 21; 143():115611. PubMed ID: 32829042 [Abstract] [Full Text] [Related]
10. Synchronous antiresorptive osteonecrosis of the jaws and breast cancer metastasis. Flores IL, dos Santos-Silva AR, Della Coletta R, Vargas PA, Lopes MA. Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Mar 21; 117(3):e264-8. PubMed ID: 24528798 [Abstract] [Full Text] [Related]
11. Antiresorptive agents-related osteonecrosis of the jaw (ARONJ) in rheumatoid arthritis. Fujieda Y, Atsumi T. J Bone Miner Metab; 2020 Sep 21; 38(5):739-741. PubMed ID: 32591907 [No Abstract] [Full Text] [Related]
12. Antiresorptive agent-related osteonecrosis of the jaw (ARONJ) in urological malignancies: a multi-center retrospective study. Sakai Y, Shindo T, Sato S, Takahashi A, Kunishima Y, Kato R, Itoh N, Okada M, Tachiki H, Taguchi K, Takayanagi A, Hotta H, Horita H, Matsukawa M, Matsuki M, Nishiyama K, Miyazaki A, Hashimoto K, Tanaka T, Masumori N. J Bone Miner Metab; 2021 Jul 21; 39(4):661-667. PubMed ID: 33704573 [Abstract] [Full Text] [Related]
13. Suppression of Bone Necrosis around Tooth Extraction Socket in a MRONJ-like Mouse Model by E-rhBMP-2 Containing Artificial Bone Graft Administration. Tanaka Y, Aung KT, Ono M, Mikai A, Dang AT, Hara ES, Tosa I, Ishibashi K, Ono-Kimura A, Nawachi K, Kuboki T, Oohashi T. Int J Mol Sci; 2021 Nov 26; 22(23):. PubMed ID: 34884630 [Abstract] [Full Text] [Related]
14. Involvement of Impaired Angiogenesis and Myelosuppression in Antiresorptive-agent Related Osteonecrosis of the Jaw Mouse Model. Igarashi H, Nishizawa S, Miyamoto T, Hikita A, Hoshi K. Tokai J Exp Clin Med; 2023 Apr 20; 48(1):22-31. PubMed ID: 36999390 [Abstract] [Full Text] [Related]
15. Primary wound closure after tooth extraction for prevention of medication-related osteonecrosis of the jaw in patients under denosumab. Matsumoto A, Sasaki M, Schmelzeisen R, Oyama Y, Mori Y, Voss PJ. Clin Oral Investig; 2017 Jan 20; 21(1):127-134. PubMed ID: 26924135 [Abstract] [Full Text] [Related]
18. Effectiveness of surgery and hyperbaric oxygen for antiresorptive agent-related osteonecrosis of the jaw: A subgroup analysis by disease stage. Watanabe T, Asai K, Fukuhara S, Uozumi R, Bessho K. PLoS One; 2021 Jan 20; 16(1):e0244859. PubMed ID: 33395446 [Abstract] [Full Text] [Related]
19. Primary wound closure and perioperative antibiotic therapy for prevention of bisphosphonate-related osteonecrosis of the jaw after tooth extraction. Spanou A, Nelson K, Ermer MA, Steybe D, Poxleitner P, Voss PJ. Quintessence Int; 2020 Jan 20; 51(3):220-228. PubMed ID: 32020132 [Abstract] [Full Text] [Related]